• linkedin
  • Increase Font
  • Sharebar

    MOC: 84% of urologists dissatisfied with current process


    Actions taken

    While discontent about MOC is common, what may be more concerning is that some urologists may put their words into action and choose not to recertify later in their career—a scenario that could negatively impact an already shrinking urologist work force. In fact, 62% of survey respondents said they do not plan to take the recertification exam when they are 60 or older or within 5 years of the end of their career. About one-fourth indicated they’ll take the recertification exam, and another 13% are already age 60 or older or within 5 years of the end of their career.

    Have you read: Which presidential candidate would be best for health care?

    In a similar Urology Times survey question posed in fall 2015, the number of respondents saying they won’t take the recertification exam when they reach age 60 was significantly lower, at 53%.

    Aspect of certification that's most bothersome

    Another possible outcome of urologists’ displeasure with the ABU’s MOC process is that they will seek certification elsewhere. One-fourth of survey respondents said they have considered obtaining board certification from an organization other than the ABU or other member board of the American Board of Medical Specialties or American Osteopathic Association.

    As many urologists know, being board certified is often a requirement to practice in U.S. hospitals. Sixty-three percent of survey respondents said they are required to be certified or recertified to practice in their hospital, 23% said no such requirement exists, and 14% didn’t know. Some states have passed or introduced legislation that removes this requirement or, in some cases, prohibits making MOC a condition of licensure. (See, “Update: States limit the role of specialty certification.")

    Also see: Congress seeks reform of self-referral law

    Most urologists (91%) do know that the ABU is separate and independent from the AUA.

    Next: What should be done

    Richard R. Kerr
    Kerr is group content director for Urology Times.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available